1,0
4 mrt 2026
Huidige werknemer, meer dan 10 jaar
New York, NY
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
None. The c suite of this company has a horrendous track record. Last week the ceo approval rate was 21% and 1.9 rating. Suddenly ballot stuffing that is done at their prior companies?
Minpunten
Everything. Look at the history of reviews. Then suddenly marketing speak reviews with a jump from 21% and 1.9 that is shady. Look at the track record, the c suite who had a 400 million equity investment walk? Ex olive and change healthcare execs?